{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:20:05Z","timestamp":1791148805337,"version":"4.1.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/bor.0000000000000082","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T17:08:42Z","timestamp":1406048922000},"page":"493-501","source":"Crossref","is-referenced-by-count":53,"title":["The role of T cells in systemic lupus erythematosus"],"prefix":"10.1097","volume":"26","author":[{"given":"Christine","family":"Konya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus.","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/BOR.0b013e32835fd682","article-title":"New therapeutics in systemic lupus erythematosus.","volume":"25","author":"Paz","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B","article-title":"Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.","volume":"44","author":"Enyedy","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J","article-title":"Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.","volume":"46","author":"Nambiar","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1172\/JCI1457","article-title":"Altered pattern of TCRCD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: deficient expression of the T cell receptor zeta chain.","volume":"101","author":"Liossis","year":"1998","journal-title":"J Clin Invest"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.4049\/jimmunol.170.6.2871","article-title":"Forced expression of the Fc receptor gamma-chain renders human T cells hyperresponsive to TCRCD3 stimulation.","volume":"170","author":"Nambiar","year":"2003","journal-title":"J Immunol"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/art.11072","article-title":"Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptorCD3-induced interleukin-2 production in patients with systemic lupus erythematosus.","volume":"48","author":"Nambiar","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice.","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar3251","article-title":"Abnormalities of T cell signaling in systemic lupus erythematosus.","volume":"13","author":"Moulton","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1074\/jbc.M109.091660","article-title":"Alternative splicing factorsplicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.","volume":"285","author":"Moulton","year":"2010","journal-title":"J Biol Chem"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1073\/pnas.1214207110","article-title":"Splicing factor SF2ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.","volume":"110","author":"Moulton","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200420345","article-title":"Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.","volume":"113","author":"Jury","year":"2004","journal-title":"J Clin Invest"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.4049\/jimmunol.172.12.7821","article-title":"Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus.","volume":"172","author":"Krishnan","year":"2004","journal-title":"J Immunol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.febslet.2008.10.006","article-title":"Lipid rafts and T-lymphocyte function: implications for autoimmunity.","volume":"582","author":"Kabouridis","year":"2008","journal-title":"FEBS Lett"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.4049\/jimmunol.181.6.4019","article-title":"Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation.","volume":"181","author":"Deng","year":"2008","journal-title":"J Immunol"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI74141","article-title":"Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.","volume":"124","author":"Kidani","year":"2014","journal-title":"J Clin Invest"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0952-7915(95)80107-3","article-title":"Transcriptional regulation of the IL-2 gene.","volume":"7","author":"Jain","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08830180490452558","article-title":"Transcriptional regulation of interleukin 2 in SLE T cells.","volume":"23","author":"Tenbrock","year":"2004","journal-title":"Int Rev Immunol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1172\/JCI110579","article-title":"Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.","volume":"69","author":"Alcocer-Varela","year":"1982","journal-title":"J Clin Invest"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","article-title":"Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).","volume":"130","author":"Linker-Israeli","year":"1983","journal-title":"J Immunol"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.immuni.2008.11.014","article-title":"A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.","volume":"30","author":"Yu","year":"2009","journal-title":"Immunity"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4CD25 high T regulatory cell function in patients with active systemic lupus erythematosus.","volume":"178","author":"Valencia","year":"2007","journal-title":"J Immunol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4049\/jimmunol.178.1.271","article-title":"IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4CD25 T cell regulatory functions.","volume":"178","author":"Wan","year":"2007","journal-title":"J Immunol"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","article-title":"IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.","volume":"97","author":"Marks-Konczalik","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1172\/JCI22854","article-title":"Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.","volume":"115","author":"Juang","year":"2005","journal-title":"J Clin Invest"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"32366","DOI":"10.1074\/jbc.M111.245811","article-title":"A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.","volume":"286","author":"Rauen","year":"2011","journal-title":"J Biol Chem"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"43429","DOI":"10.1074\/jbc.M111.299339","article-title":"cAMP-responsive element modulator (CREM) alpha protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus.","volume":"286","author":"Hedrich","year":"2011","journal-title":"J Biol Chem"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.30085","article-title":"Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calciumcalmodulin-dependent protein kinase type IV.","volume":"63","author":"Ichinose","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.1073\/pnas.1103915108","article-title":"Induction of PP2A Bbeta, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus.","volume":"108","author":"Crispin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation.","volume":"9","author":"Karin","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.4049\/jimmunol.173.5.3557","article-title":"Cyclic adenosine 5-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus.","volume":"173","author":"Kyttaris","year":"2004","journal-title":"J Immunol"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118855","article-title":"Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.","volume":"98","author":"Koshy","year":"1996","journal-title":"J Clin Invest"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1172\/JCI118643","article-title":"Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.","volume":"97","author":"Desai-Mehta","year":"1996","journal-title":"J Clin Invest"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1191\/0961203304lu1032oa","article-title":"Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.","volume":"13","author":"Sidiropoulos","year":"2004","journal-title":"Lupus"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08916930903374832","article-title":"Key role of ERK pathway signaling in lupus.","volume":"43","author":"Gorelik","year":"2010","journal-title":"Autoimmunity"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.4049\/jimmunol.179.8.5553","article-title":"Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus.","volume":"179","author":"Gorelik","year":"2007","journal-title":"J Immunol"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.4049\/jimmunol.179.7.4890","article-title":"Defective expression of Ras guanyl nucleotide-releasing protein 1 in a subset of patients with systemic lupus erythematosus.","volume":"179","author":"Yasuda","year":"2007","journal-title":"J Immunol"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1529-0131(200102)44:2<397::AID-ANR59>3.0.CO;2-N","article-title":"Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients.","volume":"44","author":"Deng","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.20255","article-title":"Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.","volume":"50","author":"Oelke","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.178.3.1938","article-title":"Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus.","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI42856","article-title":"Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice.","volume":"120","author":"Biswas","year":"2010","journal-title":"J Clin Invest"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4049\/jimmunol.1301685","article-title":"Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRLMp-Fas lpr mice.","volume":"192","author":"Fujita","year":"2014","journal-title":"J Immunol"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.4049\/jimmunol.1203275","article-title":"Cutting edge: leptin-induced RORgammat expression in CD4 T cells promotes Th17 responses in systemic lupus erythematosus.","volume":"190","author":"Yu","year":"2013","journal-title":"J Immunol"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.0901533","article-title":"Human TCR-alpha beta CD4- CD8- T cells can derive from CD8 T cells and display an inflammatory effector phenotype.","volume":"183","author":"Crispin","year":"2009","journal-title":"J Immunol"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.","volume":"181","author":"Crispin","year":"2008","journal-title":"J Immunol"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and double-negative CD4- CD8- TCR alphabeta T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.143.1.103","article-title":"T cell receptor alphabeta expressing double-negative (CD4-CD8-) and CD4 T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.","volume":"143","author":"Shivakumar","year":"1989","journal-title":"J Immunol"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"31880","DOI":"10.1074\/jbc.M113.508655","article-title":"cAMP-responsive element modulator alpha (CREMalpha) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3CD4-CD8- T cells in health and disease.","volume":"288","author":"Hedrich","year":"2013","journal-title":"J Biol Chem"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1074\/jbc.M113.523605","article-title":"cAMP responsive element modulator (CREM) alpha mediates chromatin remodeling of CD8 during the generation of CD3 CD4- CD8- T cells.","volume":"289","author":"Hedrich","year":"2014","journal-title":"J Biol Chem"},{"key":"R51-6-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1191\/0961203302lu234oa","article-title":"Characterization of CD3 CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4.","volume":"11","author":"Dean","year":"2002","journal-title":"Lupus"},{"key":"R52-6-20210128","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.161.4.1686","article-title":"TCR ligation on CD8 T cells creates double-negative cells in vivo.","volume":"161","author":"Mehal","year":"1998","journal-title":"J Immunol"},{"key":"R53-6-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1191\/0961203302lu235oa","article-title":"Characterization of CD3 CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.","volume":"11","author":"Anand","year":"2002","journal-title":"Lupus"},{"key":"R54-6-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells.","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"R55-6-20210128","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R56-6-20210128","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","article-title":"The role of IL-23IL-17 axis in lupus nephritis.","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"R57-6-20210128","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.0802626","article-title":"CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.","volume":"183","author":"Steinmetz","year":"2009","journal-title":"J Immunol"},{"key":"R58-6-20210128","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells.","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"R59-6-20210128","doi-asserted-by":"crossref","first-page":"43437","DOI":"10.1074\/jbc.M111.299313","article-title":"cAMP-responsive element modulator (CREM) alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus.","volume":"286","author":"Rauen","year":"2011","journal-title":"J Biol Chem"},{"key":"R60-6-20210128","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKTmTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance.","volume":"124","author":"Koga","year":"2014","journal-title":"J Clin Invest"},{"key":"R61-6-20210128","doi-asserted-by":"crossref","first-page":"e88441","DOI":"10.1371\/journal.pone.0088441","article-title":"T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus.","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"key":"R62-6-20210128","doi-asserted-by":"crossref","first-page":"e62855","DOI":"10.1371\/journal.pone.0062855","article-title":"T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRLlpr mice.","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"key":"R63-6-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R64-6-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/intimm\/dxt070","article-title":"Pathogenic Th2-type follicular helper T cells contribute to the development of lupus in Fas-deficient mice.","volume":"26","author":"Futatsugi-Yumikura","year":"2014","journal-title":"Int Immunol"},{"key":"R65-6-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.autrev.2010.11.004","article-title":"Follicular helper T cells in systemic lupus erythematosus: a potential therapeutic target.","volume":"10","author":"Dong","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R66-6-20210128","doi-asserted-by":"crossref","first-page":"89017","DOI":"10.1155\/2007\/89017","article-title":"IPEX as a result of mutations in FOXP3.","volume":"2007","author":"van der Vliet","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"R67-6-20210128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12026-007-0022-2","article-title":"IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.","volume":"38","author":"Ochs","year":"2007","journal-title":"Immunol Res"},{"key":"R68-6-20210128","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int Immunol"},{"key":"R69-6-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0961203307088307","article-title":"Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.","volume":"17","author":"Vargas-Rojas","year":"2008","journal-title":"Lupus"},{"key":"R70-6-20210128","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus.","volume":"183","author":"Iikuni","year":"2009","journal-title":"J Immunol"},{"key":"R71-6-20210128","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8 Treg cells are associated with immunological remission of lupus.","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"R72-6-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/gene.2009.39","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus.","volume":"10","author":"Moser","year":"2009","journal-title":"Genes Immun"},{"key":"R73-6-20210128","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0952-7915(98)80090-3","article-title":"The genetics of human systemic lupus erythematosus.","volume":"10","author":"Harley","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"R74-6-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11926-013-0369-4","article-title":"Genetics and epigenetics of systemic lupus erythematosus.","volume":"15","author":"Costa-Reis","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"R75-6-20210128","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.4049\/jimmunol.176.12.7143","article-title":"The epigenetic face of systemic lupus erythematosus.","volume":"176","author":"Ballestar","year":"2006","journal-title":"J Immunol"},{"key":"R76-6-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","article-title":"Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4 T cells from lupus patients.","volume":"43","author":"Coit","year":"2013","journal-title":"J Autoimmun"},{"key":"R77-6-20210128","doi-asserted-by":"crossref","first-page":"e1003678","DOI":"10.1371\/journal.pgen.1003678","article-title":"Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4 T-cell populations.","volume":"9","author":"Absher","year":"2013","journal-title":"PLoS Genet"},{"key":"R78-6-20210128","first-page":"411","article-title":"DNA methylation in the regulation of T cell LFA-1 expression.","volume":"29","author":"Kaplan","year":"2000","journal-title":"Immunol Invest"},{"key":"R79-6-20210128","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.4049\/jimmunol.1000340","article-title":"Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.","volume":"186","author":"Sunahori","year":"2011","journal-title":"J Immunol"},{"key":"R80-6-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaut.2013.01.005","article-title":"Impaired DNA methylation and its mechanisms in CD4()T cells of systemic lupus erythematosus.","volume":"41","author":"Zhang","year":"2013","journal-title":"J Autoimmun"},{"key":"R81-6-20210128","first-page":"804","article-title":"Abnormal histone modification patterns in lupus CD4 T cells.","volume":"35","author":"Hu","year":"2008","journal-title":"J Rheumatol"},{"key":"R82-6-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lprlpr mouse.","volume":"111","author":"Mishra","year":"2003","journal-title":"J Clin Invest"},{"key":"R83-6-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/08916934.2013.844794","article-title":"Epigenetic dysregulation in systemic lupus erythematosus.","volume":"47","author":"Liu","year":"2014","journal-title":"Autoimmunity"},{"key":"R84-6-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2012.04.005","article-title":"miRNA in systemic lupus erythematosus.","volume":"144","author":"Amarilyo","year":"2012","journal-title":"Clin Immunol"},{"key":"R85-6-20210128","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.4049\/jimmunol.0904060","article-title":"MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4 T cells by directly and indirectly targeting DNA methyltransferase 1.","volume":"184","author":"Pan","year":"2010","journal-title":"J Immunol"},{"key":"R86-6-20210128","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R87-6-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-0326-9_16","article-title":"Microarray technology for analysis of microRNA expression in renal biopsies of lupus nephritis patients.","volume":"1134","author":"Sui","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"Suppl 11","key":"R88-6-20210128","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1002\/art.38535","article-title":"A114: methylprednisolone-induced inhibition of miR-155 expression increases SOCS1-driven suppression of cytokine signaling.","volume":"66","author":"Davis","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T01:22:41Z","timestamp":1717118561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201409000-00006"}},"subtitle":["an update"],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000082","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}